Novel Markers for Adverse Events in Atrial Fibrillation

This publication has 30 references indexed in Scilit:

• Plasma Asymmetric Dimethylarginine and Adverse Events in Patients with Atrial Fibrillation Referred for Coronary Angiogram
  PLOS ONE, 2013
• Assessing bleeding risk in patients taking anticoagulants
  Journal of Thrombosis and Thrombolysis, 2013
• Effect of Atrial Fibrillation on Atrial Thrombogenesis in Humans: Impact of Rate and Rhythm
  JACC, 2013
• DDAH Says NO to ADMA
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2011
• Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease
  Vascular Medicine, 2010
• Targeted Metabolomic Evaluation of Arginine Methylation and Cardiovascular Risks
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2009
• Regulation of eNOS-Derived Superoxide by Endogenous Methylarginines
  Biochemistry, 2008
• Inflammation induces hemorrhage in thrombocytopenia
  Blood, 2008
• ADMA is independently related to flow‐mediated vasodilation in subjects at low cardiovascular risk
  European Journal of Clinical Investigation, 2007
• Effects of cardioversion of atrial fibrillation on endothelial function in hypertension or diabetes
  European Journal of Clinical Investigation, 2006